- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis Fatigue in Australia
Total 552 results
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
Medical University of ViennaNational Bank of AustriaUnknownMultiple Sclerosis | FatigueAustria
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Medical University of ViennaUnknownMultiple Sclerosis | FatigueAustria
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Merck KGaA, Darmstadt, GermanyMerck Serono Australia Pty LtdCompleted
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisAustralia, United States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustria
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Emerald Health PharmaceuticalsSuspendedRelapsing Forms of Multiple SclerosisUnited States, Australia
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
BayerCompletedMultiple Sclerosis, Relapsing RemittingBelgium, Bosnia and Herzegovina, Italy, Austria, Croatia, Czechia, France, Greece, Hungary, Spain, Switzerland
-
University of MelbourneActive, not recruitingMultiple SclerosisAustralia
-
Clene NanomedicineGeorge ClinicalCompletedRelapsing Multiple SclerosisAustralia
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany, Estonia, Latvia, Lithuania, Finland, Austria, Denmark, Netherlands, Portugal, Switzerland, Norway, Italy
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Monash UniversityEnrolling by invitationMultiple Sclerosis | Adherence, MedicationAustralia
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Pipeline Therapeutics, Inc.Completed
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
Pfenex, IncCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Melbourne HealthEastern HealthCompletedMultiple Sclerosis | TremorAustralia
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
BayerCompletedMultiple Sclerosis | Positron-Emission TomographyAustralia, Sweden
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
BiogenCompletedMultiple SclerosisUnited States, Australia, Austria, Canada
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
Medical University of ViennaRecruitingMultiple Sclerosis, Relapsing-Remitting | Optic NeuritisAustria
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
GlaxoSmithKlineCompleted
-
Clene NanomedicineClene Australia Pty LtdTerminatedRelapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With DemyelinationUnited States, Canada, Australia
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Australia, Puerto Rico, United Kingdom